Radius Health, Inc. (RDUS Quick QuoteRDUS - Free Report) was a big mover last session, as the company saw its shares jump above 10% on the day. The move came after the company posted data from a phase 1 clinical trial. Also, this led to far more shares changing hands than in a normal session. This breaks the recent trend for the company as the stock is now trading above the volatile price range of $32.88 to $37.37 in the past one-month time frame.

The company has seen two negative estimate revisions in the past 30 days. Also, its Zacks Consensus Estimate moved lower over the same timeframe. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
 
Radius Health currently carries a Zacks Rank #3 (Hold).

Radius Health, Inc. Price

Radius Health, Inc. Price | Radius Health, Inc. Quote

A better-ranked stock in the Medical – Drugs industry is Aerie Pharmaceuticals, Inc. , which holds a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is RDUS going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?                                             

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana. Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. See the pot trades we're targeting>>